Yahoo News: Cancer

Fukushima meltdown not seen causing many cancers: UN scientists

Wed, 04/02/2014 - 17:40
By Fredrik Dahl VIENNA (Reuters) - Japan's Fukushima nuclear disaster is unlikely to lead to a rise in the number of people developing cancer like after Chernobyl in 1986, even though the most exposed children may face an increased risk, U.N. scientists said on Wednesday. In a major study, the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) said it did not expect ...

Living Alone Linked with Higher Risk of Melanoma Death in Men

Wed, 04/02/2014 - 15:41
Men who live alone may have a higher risk of dying from the skin cancer melanoma compared with men who live with a partner, a new study from Sweden finds. Studies have shown that 40 to 60 percent of melanoma cases are discovered by patients themselves or their family members, the researchers said. It is possible that women are more aware than men of skin health messages and signs of skin cancer ...

GlaxoSmithKline throws in towel on lung cancer vaccine trial

Wed, 04/02/2014 - 08:08
By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline Plc (GSK) has stopped a high-profile clinical trial using a novel vaccine to fight lung cancer after deciding it will not be possible to find a sub-group of patients who might benefit. The decision comes less than two weeks after GSK said the MAGE-A3 therapeutic vaccine did not help patients with non-small cell lung cancer in the Phase III ...

Breast cancer screening a complex mix of benefits, risk -report

Tue, 04/01/2014 - 23:47
By Andrew M. Seaman NEW YORK (Reuters Health) - A review of 50 years of studies on the risks and benefits of yearly mammograms has tied them to a 19 percent drop overall in breast cancer deaths, but whether a woman benefits depends on factors such as age and family history, U.S. researchers said on Tuesday. A report published in the Journal of the American Medical Association is the latest ...

What a Mammogram Could Do for You: Study Lays Out Risk & Benefits

Tue, 04/01/2014 - 23:05
To maximize the benefits and lower the risks of routine mammograms for breast cancer screening, it's best to base decisions on each woman's individual risk level, as well as her values and priorities, researchers concluded after reviewing 50 years of studies on mammograms. Mammography is performed routinely with the goal of catching breast cancer early, but it is unclear if early diagnosis is ...

Aspirin May Extend Lives of Some Colon Cancer Patients

Tue, 04/01/2014 - 00:54
Aspirin may help some people with colon cancer live longer, according to a new study. They found 37.9 percent of those who regularly took aspirin died, compared with 48.5 percent of the patients who didn't take aspirin. However, the benefit of taking aspirin was seen only in patients whose tumors made a certain protein, called HLA class I antigen. This protein may be involved in the immune ...

FDA allows Curis to resume testing cancer drug

Mon, 03/31/2014 - 14:07
(Reuters) - Curis Inc said the U.S. Food and Drug Administration allowed it to resume testing of its experimental cancer drug, lifting a November order halting enrolment in an early-stage trial. Enrolment for the study was halted after the death of a patient with advanced breast cancer, who experienced acute liver failure about a month after the drug, codenamed CUDC-427, was discontinued. The ...

GSK pulls bid to extend use of kidney drug to ovarian cancer

Mon, 03/31/2014 - 11:56
GlaxoSmithKline on Monday withdrew an application to use Votrient, a drug licensed for kidney cancer, to treat advanced ovarian cancer after analysis of data from a late-stage trial did not support the benefit-to-risk ratio. GSK, which had applied for approval in Europe, said it would also not continue to develop the drug for advanced ovarian cancer in other countries. Votrient, which has the ...

Two Boston Hospitals Change Surgical Technique After Cancer Debate

Sat, 03/29/2014 - 12:23
High-Profile Case Linked Technique to Cancer Spread in Patient

U.S. advisers back DNA-based colon cancer test

Thu, 03/27/2014 - 19:49
(Reuters) - A colon cancer screening method that uses stool samples won the unanimous backing of a U.S. advisory panel on Thursday, paving the way for potential regulatory approval of the DNA test. A panel of outside experts to the Food and Drug Administration voted 10-0 to recommend approval of the Cologuard screening test made by Exact Sciences Corp. While a colonoscopy is considered the most ...

US Cases of Invasive Cancer Drop Slightly

Thu, 03/27/2014 - 17:03
Rates of new cancer cases in the United States have fallen slightly in recent years, according to a new report from the Centers for Disease Control and Prevention. Between 2009 and 2010, the rate of invasive cancer in the country dropped from 459 new cases per 100,000 people, to 446 new cases per 100,000 people, the report found. Invasive cancers are those that have spread beyond their site of ...

Novartis says lung cancer patients respond to drug in study

Thu, 03/27/2014 - 06:19
Novartis said late on Wednesday that a majority of patients given a development drug against non-small cell lung cancer had responded to the treatment, according to study results published in the New England Journal of Medicine. The Basel-based drugmaker's LDK378 has been declared a "breakthrough therapy", a designation created by the U.S. Food and Drug Administration in 2012 to help speed drugs ...

No surgery for former Bills QB Kelly for cancer

Wed, 03/26/2014 - 22:14
BUFFALO, N.Y. (AP) — Doctors treating Hall of Fame quarterback Jim Kelly said Wednesday he will not immediately undergo surgery for a recurrence of cancer.

Italy's MolMed close to announcing cancer drug results

Wed, 03/26/2014 - 20:48
Italy's MolMed is close to presenting results from Phase III clinical trials of a new cancer treatment that could represent a turning point for the biotech company, its founder said on Wednesday. The Milan-based company has developed the NGR-hTNF molecule to treat mesothelioma, a cancer caused by asbestos, and expects to announce results of the trials by the end of June, Claudio Bordignon told ...

Could half of all breast cancers be prevented?

Wed, 03/26/2014 - 14:08
"We really need to go back and work at breast cancer prevention starting at a young age," Dr. Graham Colditz, associated director for prevention and control at Siteman Cancer Center and Washington University in St. Louis, a co-author of the report, told Reuters Health. "Women need to have better access to understanding how breast cancer risk accumulates and how these lifestyle factors add up ...

Radiation improves odds for some women after mastectomy

Tue, 03/25/2014 - 20:59
By Andrew M. Seaman NEW YORK (Reuters Health) - Women who have their breasts removed because of cancer may benefit from receiving radiation if they still have traces of cancer in their lymph nodes, suggests a new analysis. Radiation reduced the risk of death and of cancer returning among women who had cancer cells detected in the cluster of nodes under the arms after a mastectomy. "It has been ...

Minorities most vulnerable to financial slide after breast cancer

Tue, 03/25/2014 - 20:42
By Kathryn Doyle NEW YORK (Reuters Health) - Black and Latina breast cancer patients were more than twice as likely as white women to have lingering medical debt and to skip treatments because of costs, according to a new U.S. study. "Although we were able to control for factors such as overall household income in this study, it is likely that other disparities and challenges faced by minority ...

Patrick Dempsey's mother dies of cancer at age 79

Tue, 03/25/2014 - 20:28
LEWISTON, Maine (AP) — Patrick Dempsey's mother has died of cancer six years after inspiring him to help create a cancer support organization at a hospital in Maine. Amanda Dempsey was 79.

Bills great Jim Kelly expects more cancer surgery

Tue, 03/25/2014 - 16:40
BUFFALO, N.Y. (AP) — Hall of Fame quarterback Jim Kelly is expected to have surgery again following the recurrence of cancer that his wife described as aggressive and "starting to spread."

Pfizer lung cancer drug beats chemo for previously untreated patients

Tue, 03/25/2014 - 14:02
(Reuters) - Pfizer Inc's Xalkori delayed progression of lung cancer longer than chemotherapy in patients who had never previously been treated for the disease, according to results of a late-stage study released on Tuesday. The medicine, which received U.S. approval in 2011 for lung cancer patients who have a specific gene mutation, had shown in a previous Phase III trial that it significantly ...